Please login to the form below
Illumina
This page shows the latest Illumina news and features for those working in and with pharma, biotech and healthcare.
Roche buys gene sequencing firm
Illumina to the altar. ... which is predicted to swell to $8.7bn by 2020 but at the moment is still dominated by Illumina with around 75% market share,.
Latest news
-
AstraZeneca joins Genomics England consortium
AstraZeneca joins Genomics England consortium. Combines with other pharma firms such as Illumina to utilise genetic data to create new medicines. ... It joins another of other firms, including Biogen and Illumina, who have signed up to the project.
-
NHS set to deliver 'world-leading' genomics centres
After samples are collected, they will be sent securely to its gene sequencing partner Illumina - results will be returned to the NHS for validation and clinical action.
-
AZ advances immuno-oncology ambitions
Buys imaging company and signs PD-1 collaborations with Pharmacyclics and J&J
-
AZ and Redx collaborate on genetics of cancer
The company also recently announced a partnership with gene sequencing specialist Illumina and two other pharma companies – Sanofi and Janssen – to develop a universal diagnostics tool for cancer to support the
-
Illumina partners with pharma majors on cancer diagnostic
Illumina partners with pharma majors on cancer diagnostic. Will work with AstraZeneca, Janssen and Sanofi to develop gene sequencing tool. ... According to Illumina, the potential in the area is huge, with 125 genes that drive the growth of cancer known
More from news
Approximately 5 fully matching, plus 19 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2017
IBM Watson Health/ Illumina. Partnership to integrate Watson for Genomics into Illumina's BaseSpace Sequence Hub and tumour sequencing process to expand access to genomic data.
-
Digital: Fallacy or the Future Face of Pharma Marketing?
Speakers. Dan Coffin, Global Head of Illuminas Health. Dan now heads up the global pharmaceutical arm of Illuminas and brings an interesting mix of experiences having worked agency side at Isis
-
Digital: Fallacy or the Future Face of Pharma Marketing?
Speakers. Dan Coffin, Global Head of Illuminas Health. Dan now heads up the global pharmaceutical arm of Illuminas and brings an interesting mix of experiences having worked agency side at Isis
-
Pharma deals during July 2013
Roche, rumoured to be interested in Alexion, may still be smarting from the battle to try and take over Illumina last year.
-
What can pharma learn from Olympic sports coverage?
So where could Roche go next? With its unsuccessful takeover bid for Illumina, it could be a move into genetic sequencing to augment their oncology capability and more besides.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
Illumina expands board of directors
Illumina expands board of directors. John Thompson brings experience from IBM and Microsoft. ... San Diego, US-based Illumina has appointed John Thompson to its board of directors.
-
GlobalData makes Americas appointment
He has spent 18 years in varous positions in the life sciences consulting industry, including roles at, Bionest Partners, IMS Management Consulting, and Illumina Inc.
More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Why is the UK lagging behind the rest of Europe in cancer survival?
To bring home the importance of this diagnostic technology, the CEO of Illumina (a top DNA sequencing firm) believes this technology will become the “ stethoscope for the next 200 years.” A
-
Why is the UK lagging behind the rest of Europe in cancer survival?
To bring home the importance of this diagnostic technology, the CEO of Illumina (a top DNA sequencing firm) believes this technology will become the “ stethoscope for the next 200 years.” A
-
Dan Coffin joins London Headquarters as Director
Most recently, Dan was employed at Illuminas where he established and ran their healthcare market research arm.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Featured jobs
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Account Manager – Med Comms – London
-
Salary TBC
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
-
Senior Medical Writer
-
Great salary and bebefits
-
Senior Medical Writer
-
Great salary and benefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
-
Scientific Director
-
Great salary and bebefits
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Senior Programme Executive
-
Salary TBC
Subscribe to our email news alerts
PMHub
Say Communications
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...
Latest intelligence
- No Voice, No Choice
- Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
- Pharma’s isolated islands of innovation
- With service design and technology often failing the patient, why perspective on improving outcomes need to change...
- Uncertainty, austerity and Brexit
- What does it mean for the life science sector?...
Quick links
Infographics
